Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06199492 · ClinicalTrials.gov registry record · NA
Intelligent Optical Probe for Guiding Core Needle Biopsy Procedures
A NA study of Needle Biopsy, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06199492 is a NA study of Needle Biopsy that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06199492, a NA study of Needle Biopsy, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if an investigational imaging device can help to identify tumor tissue before a biopsy is taken.
Conditions Studied
Interventions
- DEVICE tVisio-1
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-12-05 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06199492
The ClinicalTrials.gov registry entry for NCT06199492 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Needle Biopsy appearing as the primary indexed condition, and to 1 intervention - of which tVisio-1 is the first listed.
NCT06199492 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06199492 about?
NCT06199492 is a clinical study titled "Intelligent Optical Probe for Guiding Core Needle Biopsy Procedures". To learn if an investigational imaging device can help to identify tumor tissue before a biopsy is taken.
What is the current status of trial NCT06199492?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-12-05. Estimated completion is 2027-05-31.
What conditions does trial NCT06199492 study?
This clinical trial studies the following conditions: Needle Biopsy.
What interventions are being tested in trial NCT06199492?
The interventions under investigation include: tVisio-1 (DEVICE).
Who is sponsoring clinical trial NCT06199492?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06199492 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.